Archive
This is my archive
Delos Capital and AP Biosciences Inc. Launch Collaboration to Create New Biotech Companies Focused on Next-Generation Antibodies
Dr. Eric Huang, Operating Partner at Delos, was awarded the 2022 Warren Alpert Foundation Prize
We would like to congratulate Dr. Eric Huang, Operating Partner at Delos Capital for being presented with the prestigious 2022 Warren Alpert Foundation Prize! Each year the recipient(s) of the Warren Alpert Foundation Prize are recognized at a scientific symposium hosted by Harvard Medical School. 2022 WARREN ALPERT… Read More
Delos Capital Announces $300 Million First Close of its Third Life Sciences Fund
HONG KONG, Feb. 15, 2022 /PRNewswire/ — Delos Capital, a Hong Kong-headquartered life sciences venture capital fund with a global presence and investment mandate, announces the successful $300 million first close of its Fund III. The first close of Fund III was completed in only 6 months of fundraising and attracted commitments from reputable investors… Read More